Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Where our team of guest writers discuss what they think about the current NGP US Issues.
Director of Business Development
Can digital pathology save drug development?
Peter Duncan of Definiens discusses the potential of digital pathology.07 Jul 2010
Focus Area: Drug Discovery
The ion age
Ion channels are of great interest to the pharmaceutical industry since they represent important therapeutic targets
Executive forum: Vital statistics
Informatics has the potential to drive growth in the worldwide pharmaceuticals drug market to a massive US$3 trillion by 2020, according to research
Executive forum: Vital statistics
Informatics has the potential to drive growth in the worldwide pharmaceuticals drug market to a massive US$3 trillion by 2020, according to research
Executive forum: Vital statistics
Informatics has the potential to drive growth in the worldwide pharmaceuticals drug market to a massive US$3 trillion by 2020, according to research
The Confusion around COTS
By Richard Wagner
In software for the pharmaceutical industry, these days it seems like “COTS” (Commercial Off-The-Shelf) is inescapable.
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.